• November 16, 2018

Generex Confirms & Clarifies 20:1 Common Stock Dividend - Odessa American: Business

e-Edition Subscribe

Generex Confirms & Clarifies 20:1 Common Stock Dividend

Print
Font Size:
Default font size
Larger font size

Posted: Monday, October 22, 2018 8:04 am

MIRAMAR, Fla.--(BUSINESS WIRE)--Oct 22, 2018--Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) today confirmed its previously announced plan to issue a 20:1 stock dividend. The announcement today includes a clarification of the stock dividend process and how it is different from a forward spilt.

On October 10, 2018 the Company announced that its Board of Directors had approved the issuance of 20 shares of common stock for every one share of issued and outstanding common stock. As of today, there are 1,068,100 shares of the Company’s common stock issued and outstanding. The Company has an obligation to issue additional shares to satisfy certain outstanding option, warrant and convertible security commitments. All options, warrants, and convertible securities of the Company outstanding on the record date will be proportionally adjusted to reflect the dividend.

“With a stock dividend, an in-kind dividend is declared by the Board of Directors,” explained President & Chief Executive Officer Joseph Moscato. “Existing shareholders on the record date will not have to do anything, they will receive the additional shares, on a pro-rata basis, in the amount of the dividend. For every share of stock a shareholder owns on the record date, they will receive twenty new dividend shares. For every one share of stock a shareholder owns, following the dividend, they will own 21 shares. For shares held in a brokerage account, the dividend shares will show up in that account. For shares held in certificate format, the dividend shares will be issued via book entry and shareholders will have the option of requesting a physical certificate.”

Mr. Moscato continued, “A stock dividend of this nature is different from a forward split. If the Company were executing a forward split, all shares owned by shareholders would be collected and new shares would be issued. For instance, in a 20:1 forward split, for every share a shareholder returned to the Company, that shareholder would be issued 20 new shares. After a forward split, for every share held by shareholders they would own 20 shares of a newly issued stock. Generex is executing a stock dividend, not a forward spilt.”

It is important to note that this pro rata common stock dividend is not a forward stock split.There will be no change in: the Company’s ticker symbol; the Company’s CUSIP number; the par or stated value of the Company’s common stock; or the Company’s Restated Certificate of Incorporation.In addition, there will be no automatic adjustment of the stock price as there would be with a forward split and the newly issued stock will have the same trading characteristics as the underlying securities.

No shareholder action will be required in respect of this in-kind dividend.

The Company will announce record and payment dates in respect of the stock dividend in due course following the completion of requisite regulatory filings.

Cautionary Note Regarding Forward-Looking Statements

This release and oral statements made from time to time by Generex representatives in respect of the same subject matter may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by introductory words such as "expects," "plan," "believes," "will," "achieve," "anticipate," "would," "should," "subject to" or words of similar meaning, and by the fact that they do not relate strictly to historical or current facts. Forward-looking statements frequently are used in discussing potential product applications, potential collaborations, product development activities, clinical studies, regulatory submissions and approvals, and similar operating matters. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known and others of which are not. Known risks and uncertainties include those identified from time to time in the reports filed by Generex with the Securities and Exchange Commission, which should be considered together with any forward-looking statement. No forward-looking statement is a guarantee of future results or events, and one should avoid placing undue reliance on such statements. Generex undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.Generex claims the protection of the safe harbor for forward-looking statements that is contained in the Private Securities Litigation Reform Act.

View source version on businesswire.com:https://www.businesswire.com/news/home/20181022005284/en/

CONTACT: Generex Biotechnology Corporation

Joseph Moscato, 646-599-6222

or

Todd Falls, 800-391-6755 Extension 222

investor@generex.com

or

Russo Partners

Investor / Media Contacts:

Alex Fudukidis, 646-942-5632

alex.fudukidis@russopartnersllc.com

or

Caroline Cunningham, 212-845-4292

Caroline.Cunningham@russopartnersllc.com

KEYWORD: UNITED STATES NORTH AMERICA FLORIDA

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY

SOURCE: Generex Biotechnology Corporation

Copyright Business Wire 2018.

PUB: 10/22/2018 09:00 AM/DISC: 10/22/2018 09:04 AM

http://www.businesswire.com/news/home/20181022005284/en

© 2018 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Odessa, TX

Current Conditions

Sunny
68°
Humidity: 17%
Winds: SSW at 9mph
Feels Like: 68°

Your Extended Forecast

Tomorrow

weather
High 69°/Low 37°
Sunny. Highs in the upper 60s and lows in the upper 30s.

saturday

weather
High 65°/Low 33°
A few clouds. Highs in the mid 60s and lows in the low 30s.

sunday

weather
High 50°/Low 34°
Times of sun and clouds. Highs in the low 50s and lows in the mid 30s.
Online Features

Pet Central

pets

Having a pet is a lot of responsibility, and we’ll help by giving you lots of tips and tricks! More >>

Fitness

Fitness

Our fitness articles will help teach you how to work out with gym- and home-based exercises. More >>

Crosswords

Crosswords

Enjoy the crosswords challenge in our free daily puzzles, from the harder Sunday crossword to the quicker daily. More >>

Sudoku

Sudoku

Every Sudoku has a unique solution that can be reached logically. Enter numbers into the blank spaces so that each row, column and 3x3 box contains the numbers 1 to 9. More >>




  • ALL-ACCESS: Subscribe to our e-edition and premium website at myoaoa.com.
    You can read your daily newspaper without taking a walk to the driveway.
    Look back at yesterday's newspaper, or issues from months ago with our archive feature.
    Call circulation at 432-337-7670 to sign up today.